-
Stocks lower as Hormuz concerns and high oil prices persist
-
Rain halts India push after Dinusha century lifts Sri Lanka
-
Crowds turn out for 'Total Eclipse' singer Bonnie Tyler's funeral
-
Dinusha hits century as Sri Lanka post 284 in first India Test
-
Mali jails junta-critic broadcaster, influencer for seven years
-
Stocks steady as investors weigh US rate path
-
'Nowhere to run': Indonesian quake survivors plead for help
-
Taiwan's leader says government to propose record defence spending for 2027
-
Belgium fire makes 'limited' spread overnight, more help on way
-
Cambridge head slams 'feeding frenzy' over dead academic
-
Vingegaard brings curtain down on season
-
Ebola outbreak now DR Congo's deadliest ever
-
Dickwella, Dinusha hit fifties as Sri Lanka fight back
-
Germany's coalition split over putting climate in constitution
-
Bangladesh Test cricket reboot delivers in style with historic win
-
Ukraine badminton star: 'How can you feel normal when bombs are falling?'
-
Virgin moves closer to launching Eurostar rival in 2030
-
Rain brings respite as Belgium wrestles massive wildfire
-
Indian marble waste dump becomes unlikely tourist attraction
-
Most stocks rise as US data ease rate fears but fuel economic worries
-
Coach says Australia 'let standards slip' in shock Bangladesh loss
-
India take control of Galle Test as Sri Lanka slump to 99-5
-
Hawaii recovery efforts begin as Lala downgraded, moves west
-
Australia's mushroom murderer appeals conviction
-
Food safety crackdown snares Mumbai's famed restaurants
-
The Nigerian fishing community being eaten up by the Atlantic
-
Trump says US scaling back military drills with Seoul hours before start
-
Kushner to meet Netanyahu after talks with Hamas on Gaza plan
-
Nearly 13,000 displaced after deadly Indonesian quake
-
Photos, memories all that remain for Colombia's bereaved after quake
-
Axe hangs over Australian batters after Darwin 'disaster'
-
Sabalenka squeezes out win on sixth match point in Cincinnati
-
Is this cave in Turkey where Homer wrote 'The Odyssey'?
-
Trump says US scaling back military drills with South Korea hours before start
-
Winning back walls from gangs, artists fill El Salvador's towns with color
-
Jason Arday: UK academic who died amid plagiarism storm
-
Opening arguments expected in Tupac murder trial
-
Sabbath cafe clash lays bare Israel faultlines
-
As machinery removes rubble, hopes for survivors from Colombian quake dwindle
-
Top-ranked Scheffler powers to PGA St. Jude Championship victory
-
Trump says US scaling back military drills with South Korea
-
Jacquet scores on Liverpool debut in friendly win over Como
-
Zambia's Hichilema takes early lead in reelection bid
-
Hawaii's Big Island begins recovery efforts as Hurricane Lala downgrades, moves west
-
Sabalenka squeezes out a win on sixth match point in Cincinnati
-
Spidey swings high for third weekend in N. American box office
-
Duplantis dominant, Hunt hits four and Asher-Smith makes history
-
Eagle and late birdie lift Jeeno to LPGA Portland Classic win
-
Spanish soldier dies in Aragon wildfire
-
Duplantis masterclass for fourth Euro pole vault title
Sacklers, Purdue to pay $7.4 bn over opioid crisis
Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims and the authorities.
Thursday's settlement, which will see funds routed to communities and individuals affected by opioids, is the largest of several targeting the makers and sellers of the highly addictive drugs.
The $7.4 billion settlement was agreed "in principle with members of the Sackler family and their company Purdue Pharma for their instrumental role in creating the opioid crisis," New York Attorney General Letitia James's office said in a statement.
"The settlement ends the Sacklers's control of Purdue and ability to sell opioids in the United States and will deliver funding directly to communities across the country over the next 15 years to support opioid addiction treatment, prevention, and recovery programs.
"The $7.4 billion settlement in principle (is) the nation's largest."
Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products through aggressive marketing tactics while hiding how addictive the drugs are.
- Litigation avalanche -
Facing an avalanche of litigation, in 2021 Purdue pled guilty to three criminal charges over its marketing of OxyContin.
The Sacklers have consistently denied wrongdoing over the opioid crisis.
The settlement featured some 15 states including New York, Florida and Pennsylvania.
"The Sackler family relentlessly pursued profit at the expense of vulnerable patients, and played a critical role in starting and fueling the opioid epidemic," James said in a statement.
"While no amount of money will ever fully repair the damage they caused, this massive influx of funds will bring resources to communities in need so that we can heal."
The settlement includes the eight heirs of the original Purdue founders Raymond and Mortimer Sackler who served on the company board -- Richard, Kathe, Mortimer Jr, Ilene, David, and Theresa Sackler.
For many people, opioid addiction begins with prescribed pain pills, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Opioid victims and their families addressed the Sackler family, owners of Purdue Pharma, the maker of OxyContin, directly in a US courtroom in March 2022 as part of the company's bankruptcy case.
"We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons, who died at ages 32 and 25 after years of dealing with opioid addictions.
"Two boys are gone because of your 'safe' medication," Fitzgerald said.
F.Ferraz--PC